Cannabinoid Receptor Protects Against Hearing Loss Caused by Chemotherapy “ One of the side effects of common anticancer medication, is hearing loss. Activation of CB2R appears to prevent this, indicating an important role of the ECS in neuroprotection."
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss. https://t.co/300k6XYI8P
RT @FrontNeurosci: The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss: Sumana Ghosh, Sandeep…
RT @FrontNeurosci: The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss: Sumana Ghosh, Sandeep…